 The purpose of the study is to evaluate the safety and tolerability of single ascending SAD oral doses of SHR0302 compared to placebo. Also, pharmacokinetics PK and pharmacodynamics PD of SHR0302 after single oral administration will be evaluated, and, if applicable, the maximum tolerated dose determined. 